E. coli gets into your blood when bacteria that normally live harmlessly in your gut, urinary tract, or another part of your body break through protective barriers and enter the bloodstream. This condition, called E. coli bacteremia, is one of the most common types of bloodstream infection, and it most often starts as a urinary tract infection that spreads.
The Most Common Routes Into the Blood
E. coli naturally lives in your intestines and usually causes no harm there. Problems start when these bacteria reach places they don’t belong, like the bladder, abdominal cavity, or bloodstream. Once in a new compartment, E. coli faces different conditions and can trigger a serious immune response.
The most frequent path is through the urinary tract. A bladder or kidney infection caused by E. coli can spread into surrounding tissue and eventually into the bloodstream, especially if the infection goes untreated. Among adults over 80 hospitalized with E. coli in their blood, roughly 61% had a urinary tract source. In younger adults, the urinary tract is still the leading origin, though at a slightly lower rate (around 51%).
The second major route is through the gut wall. Your intestinal lining acts as a barrier that keeps bacteria contained. When that barrier is damaged, whether from inflammation, surgery, or certain medications, bacteria can cross into the bloodstream. This process is called bacterial translocation. Cancer chemotherapy drugs, for example, directly disrupt the intestinal lining and shift the balance of gut bacteria, creating openings for E. coli to slip through.
Other sources include infections in the bile ducts (hepatobiliary infections), abdominal infections from conditions like appendicitis or diverticulitis, and lung infections in severe cases. These non-urinary sources tend to be more dangerous. Studies of hospitalized patients show that people whose bloodstream infection originated from a hepatobiliary or abdominal source were more likely to die than those with a urinary source.
How Medical Devices Play a Role
Catheters and other devices that enter the body create a direct pathway for bacteria to reach the bloodstream. E. coli can form a thin, sticky layer called a biofilm on the surface of a catheter. Over time, cells from this biofilm break off and disperse directly into the blood, causing what’s known as a catheter-related bloodstream infection.
This can happen with several types of devices: central venous catheters (both tunneled and non-tunneled), port-a-caths used for chemotherapy, PICC lines placed in the arm, and even standard peripheral IVs. Urinary catheters are another common culprit, since they sit directly in the urinary tract where E. coli thrives. The longer any catheter stays in place, the greater the risk.
Who Is Most Vulnerable
Your immune system is the main line of defense against bacteria entering the blood, so anything that weakens it raises your risk significantly. Older adults face a combination of threats: the immune system gradually loses effectiveness with age, chronic conditions like diabetes and kidney disease impair the body’s ability to fight infection, and malnutrition (particularly low protein levels in the blood) further reduces resilience. In one study, 41% of patients who died from E. coli bacteremia had abnormally low albumin levels, compared to 20% of survivors.
People undergoing cancer treatment are especially vulnerable. Chemotherapy suppresses both the immune system and the integrity of the gut lining simultaneously, creating a perfect setup for bacterial translocation. Patients with blood cancers like leukemia face particularly high rates of E. coli crossing from the gut into the bloodstream.
Other high-risk groups include people on dialysis, those with liver disease, anyone taking immunosuppressive medications, and people who have recently had abdominal surgery. Essentially, if your immune system is compromised or your body’s natural barriers have been disrupted, E. coli has a much easier path into the blood.
What It Feels Like When E. Coli Reaches the Blood
A bloodstream infection with E. coli triggers a systemic response. The hallmark signs are a high fever (often above 103°F), chills, and a rapid heart rate. As the infection progresses, you may feel extreme weakness or lethargy, confusion or difficulty thinking clearly, and produce very little urine. Frequent vomiting and an inability to keep fluids down are also common.
These symptoms can escalate quickly. Nearly two-thirds of older adults with invasive E. coli disease develop sepsis, which is the body’s overwhelming and potentially life-threatening response to the infection. In sepsis, your blood pressure drops dangerously low, organs begin to struggle, and without treatment, the situation can become fatal within hours.
How It’s Diagnosed and Treated
Diagnosis requires a blood culture, where a sample of your blood is placed in a lab environment that encourages bacterial growth. If E. coli is present, the lab can identify it and test which antibiotics will kill it. These cultures are ideally drawn before antibiotics are started, though treatment shouldn’t be delayed if drawing blood takes too long.
Treatment centers on antibiotics, and the specific choice depends on which drugs the particular strain of E. coli is susceptible to. Some strains have developed resistance to common antibiotics, which makes the culture results critical for guiding treatment. For most uncomplicated cases, a 7-day course of antibiotics is the standard recommendation, counting from the first day you receive a drug that’s effective against the specific bacteria found in your blood.
Many patients start on intravenous antibiotics in the hospital and transition to oral medications once they’re stable and improving. The shift to pills at home is possible for many people, but infections caused by highly resistant strains may require longer IV treatment. Patient-specific factors like kidney function, allergies, and the original source of infection all influence which antibiotic is chosen and how long treatment lasts.
Why the Source Matters for Recovery
Not all E. coli bloodstream infections carry the same risk. When the bacteria entered from a urinary tract infection, outcomes tend to be better, likely because UTIs are caught earlier and respond well to antibiotics. When the source is an abdominal or bile duct infection, the situation is generally more serious, often requiring additional interventions like drainage procedures alongside antibiotics.
How quickly appropriate treatment begins also makes a major difference. Patients who received antibiotics that turned out to be ineffective against their particular strain of E. coli had worse outcomes than those who received the right drug from the start. This is one reason blood cultures are so important: they tell doctors whether the initial antibiotic choice is actually working, and allow a switch if it isn’t.